These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6333468)

  • 1. Lymphokine/monokine inhibition of fibroblast proliferation and collagen production: role in progressive systemic sclerosis (PSS).
    Duncan MR; Perlish JS; Fleischmajer R
    J Invest Dermatol; 1984 Nov; 83(5):377-84. PubMed ID: 6333468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation.
    Duncan MR; Berman B
    J Exp Med; 1985 Aug; 162(2):516-27. PubMed ID: 2410528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological modulation of dermal fibroblasts in scleroderma.
    Perlish JS; Fleischmajer R
    Immunol Ser; 1989; 46():605-24. PubMed ID: 2488871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients.
    Whiteside TL; Worrall JG; Prince RK; Buckingham RB; Rodnan GP
    Arthritis Rheum; 1985 Feb; 28(2):188-97. PubMed ID: 3970734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased production of an interleukin 1 (IL-1) inhibitor with fibroblast stimulating activity by mononuclear cells from patients with scleroderma.
    Sandborg CI; Berman MA; Andrews BS; Mirick GR; Friou GJ
    Clin Exp Immunol; 1986 Nov; 66(2):312-9. PubMed ID: 3493098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lymphokines and monokines in fibrosis.
    Wahl SM
    Ann N Y Acad Sci; 1985; 460():224-31. PubMed ID: 3868948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of excessive scleroderma fibroblast collagen production by lymphokines from normal human mononuclear cells.
    Jimenez SA; McArthur WM; Bashey RI; Rosenbloom J
    Arthritis Rheum; 1985 May; 28(5):502-10. PubMed ID: 4004960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in scleroderma.
    Feghali CA; Boulware DW; Levy LS
    J Rheumatol; 1992 Aug; 19(8):1212-9. PubMed ID: 1404156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis.
    Gay RE; Buckingham RB; Prince RK; Gay S; Rodnan GP; Miller EJ
    Arthritis Rheum; 1980 Feb; 23(2):190-6. PubMed ID: 6987989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast markers in labial salivary gland biopsies in progressive systemic sclerosis.
    Janin A; Konttinen YT; Grönblad M; Karhunen P; Gosset D; Malmström M
    Clin Exp Rheumatol; 1990; 8(3):237-42. PubMed ID: 2165882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immune dysfunction and the pathogenesis of scleroderma.
    Jiménez SA
    Semin Arthritis Rheum; 1983 Aug; 13(1 Suppl 1):104-13. PubMed ID: 6353581
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons.
    Duncan MR; Berman B
    J Clin Invest; 1987 May; 79(5):1318-24. PubMed ID: 2437154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII in scleroderma: in vitro studies.
    Paye M; Read D; Nusgens B; Lapiere CM
    Br J Dermatol; 1990 Mar; 122(3):371-82. PubMed ID: 1969747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of progressive systemic sclerosis.
    Haustein UF; Herrmann K; Böhme HJ
    Int J Dermatol; 1986 Jun; 25(5):286-93. PubMed ID: 3522447
    [No Abstract]   [Full Text] [Related]  

  • 15. Host immune factors regulating fibrosis.
    Wahl SM
    Ciba Found Symp; 1985; 114():175-95. PubMed ID: 3851721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Products of activated mononuclear cells modulate accumulation of collagen by normal dermal and scleroderma fibroblasts in culture.
    Whiteside TL; Buckingham RB; Prince RK; Rodnan GP
    J Lab Clin Med; 1984 Sep; 104(3):355-69. PubMed ID: 6088655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented interleukin-6 secretion in collagen-stimulated peripheral blood mononuclear cells from patients with systemic sclerosis.
    Gurram M; Pahwa S; Frieri M
    Ann Allergy; 1994 Dec; 73(6):493-6. PubMed ID: 7998663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Association with a coordinate decrease in types I and III procollagen messenger RNA levels.
    Rosenbloom J; Feldman G; Freundlich B; Jimenez SA
    Arthritis Rheum; 1986 Jul; 29(7):851-6. PubMed ID: 3091039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin-mediated inhibition of lymphokine secretion in normal individuals and patients with progressive systemic sclerosis (scleroderma, PSS).
    Kelly RH; Miller DH; Rodnan GP; Hagmann J
    Agents Actions; 1982 Oct; 12(4):471-7. PubMed ID: 6295107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.